Healthia (ASX: HLA) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Healthia Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Healthia (ASX: HLA)
    Latest News

    chart showing an increasing share price
    Growth Shares

    2 ASX shares that could be good buys for both growth and dividends

    Here are two leading ASX shares that could produce both dividends and growth.

    Read more »

    A man in a wheelchair stretches both arms into the air in success.
    52-Week Highs

    This small-cap ASX healthcare share just hit a 52-week high

    It's been a great week for the healthcare company's shares...

    Read more »

    growth charts with small cap written on a sticky note
    Small Cap Shares

    2 small cap ASX shares for 2022 with big potential

    Here are 2 small cap ASX shares with significant growth potential.

    Read more »

    Group of doctors celebrate by pumping fists in the air
    Healthcare Shares

    These were the best performing ASX healthcare shares in October

    These names sit on the podium for ASX healthcare performers last month.

    Read more »

    steps to picking asx shares represented by four lightbulbs drawn on chalk board
    Growth Shares

    2 impressive ASX shares that could be buys in November 2021

    Lovisa and Healthia are two ASX shares that could be contenders this month

    Read more »

    three excited doctors with hands in the air
    Share Gainers

    These 3 ASX Healthcare shares have surged over 10% today

    These ASX Healthcare shares have stood out today.

    Read more »

    four excited doctors with their hands in the air
    Mergers & Acquisitions

    Why the Healthia (ASX:HLA) share price is rocketing 10% today

    The healthcare company is increasing its presence with another acquisition...

    Read more »

    The word growth with bles arrows shooting up above it, indicating a share price movement for ASX growth stocks
    Growth Shares

    2 ASX shares that may be worth looking at this weekend

    Healthia and Pacific Current are two ASX shares worth thinking about.

    Read more »

    growth charts with small cap written on a sticky note
    Small Cap Shares

    2 exciting small cap ASX shares that could be buys

    Healthia is one of two small cap ASX shares that may be exciting ideas to consider.

    Read more »

    Monash Investors co-founder and director Simon Shields
    Ask a Fund Manager

    2 still-cheap ASX shares we've made buckets of money from: analyst

    Ask A Fund Manager: Monash Investors' Simon Shields tells us two stocks that have already returned 71% and 94%, but…

    Read more »

    steps to picking asx shares represented by four lightbulbs drawn on chalk board
    Growth Shares

    2 little known ASX growth shares to buy

    These 2 little-known ASX growth shares have lots of growth potential. One of them is Volpara Health Technologies Ltd (ASX:VHT).

    Read more »

    A man stands with arms crossed in front of a giant shadow of a body builder representing ASX small-cap stocks.
    Small Cap Shares

    2 small cap ASX shares that are growing quickly

    These 2 small cap ASX shares are growing really quickly. Audinate Group Ltd (ASX:AD8) is going through a recovery.

    Read more »

    Frequently Asked Questions

    Yes, Healthia has historically paid two fully franked dividends a year.

    Healthia has generally paid its shareholder dividends in March and September/October.

    Healthia Ltd listed on the ASX on 11 September 2018.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    03 Mar 2023 $0.0200 100.00% Interim 27 Mar 2023
    03 Mar 2022 $0.0200 100.00% Interim 24 Mar 2022
    07 Sep 2021 $0.0250 100.00% Final 27 Oct 2021
    02 Mar 2021 $0.0200 100.00% Interim 23 Mar 2021
    08 Sep 2020 $0.0200 100.00% Final 28 Sep 2020

    HLA ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Healthia

    Healthia Ltd (ASX: HLA) is an Australian holding company that operates allied health services, including podiatry, optometry, and physiotherapy. The company owns and operates My FootDr podiatry clinics, Allsports physiotherapy and sports medicine clinics, iOrthotics, Optical Co optometry stores, as well as other health brands.

    Healthia's podiatry division provides podiatry services and podiatry-related services including the manufacturing and sale of orthotics and other podiatry products. The company also operates Natural Fit Footwear retail stores.

    The company's physiotherapy segment provides sports and general physiotherapy, specialty hand therapy services, and operates rehabilitation clinics.

    In all, the company operates more than 30 allied health brands.

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    01 Dec 2023 Colin Kangisser Issued 406,268 $729,251
    Conversion of securities.
    01 Dec 2023 Lisa Roach Issued 407,322 $731,142
    Conversion of securities.
    01 Dec 2023 Lisa Roach Exercise 407,322 $731,142
    Conversion of securities.
    01 Dec 2023 Colin Kangisser Exercise 406,268 $729,251
    Conversion of securities.
    30 Nov 2023 Wesley Coote Issued 1,173,750 $2,106,881
    Conversion of securities. As per announcement on 04-12-2023
    30 Nov 2023 Wesley Coote Exercise 1,173,750 $2,106,881
    Conversion of securities.
    30 Oct 2023 Lisa Roach Issued 45,000 $79,425
    Conversion of securities.
    30 Oct 2023 Wesley Coote Exercise 96,250 $169,881
    Conversion of securities. 1,173,750 Rights
    30 Oct 2023 Lisa Roach Exercise 45,000 $79,425
    Conversion of securities. 407,322 Rights
    30 Oct 2023 Wesley Coote Issued 96,250 $169,881
    Conversion of securities.
    27 Mar 2023 Wesley Coote Issued 890,000 $1,076,900
    Director remuneration. 1,270,000 Performance rights, http://www.aspecthuntley.com.au/asxdata/20230403/pdf/02650665.pdf
    27 Mar 2023 Paul Wilson Issued 31,330 $39,043
    Dividend Reinvestment Plan (DRP).
    27 Mar 2023 Lisa Roach Issued 10,031 $12,500
    Dividend Reinvestment Plan (DRP).
    27 Mar 2023 Lisa Roach Issued 296,322 $358,549
    Director remuneration. 452,322 Rights, http://www.aspecthuntley.com.au/asxdata/20230403/pdf/02650665.pdf
    27 Mar 2023 Colin Kangisser Issued 361,268 $437,134
    Director remuneration. 406,268 Performance Rights, http://www.aspecthuntley.com.au/asxdata/20230403/pdf/02650665.pdf
    27 Mar 2023 Wesley Coote Issued 7,541 $9,397
    Dividend Reinvestment Plan (DRP).
    27 Mar 2023 Lisa Dalton Issued 750 $934
    Dividend Reinvestment Plan (DRP).
    27 Mar 2023 Lisa Roach Issued 364 $453
    Dividend Reinvestment Plan (DRP).

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Ms Lisa Jane Dalton Non-Executive Director May 2018
    Ms Dalton is an experienced director, senior executive and company secretary with experience in the healthcare, medical, utilities, manufacturing, childcare, energy, mining and construction sectors. She has experience in leading teams responsible for strategy, governance, risk management, human resources, communication, stakeholder relations and program management. Lisa has participated in 4 ASX listings in the past 5 years. Lisa has practical experience in fit for purpose governance, risk management, strategic planning and motivating teams to find solutions to complex issues. She is Member of Risk Committee.
    Dr Glen Frank Richards Non-Executive ChairmanNon-Executive Director May 2018
    Mr Richards is a veterinary surgeon. He has spent over 20 years building a multimillion-dollar integrated pet care empire, which now operates more than 180 veterinary hospitals and 230 pet care retail stores in Australia and Animates in New Zealand. He is a member of Risk Committee.
    Mr Wesley James Coote Chief Executive OfficerManaging Director Apr 2019
    Mr Coote is the former Chief Financial Officer and Company Secretary of Greencross Ltd. Prior to Greencross, Wesley worked in Chartered Accounting where he provided business advice within the health sector, property sector and financial services industry. Wesley joined the Group in December 2015 as Chief Financial Officer and Company Secretary and was appointed Group Managing Director and Chief Executive Officer on 29 April 2019.
    Mr Paul David Wilson Non-Executive Director May 2018
    Mr Wilson was a co-founder, director and shareholder of Mammoth Pet Holdings Pty Ltd (Pet Barn) prior to the merger with Greencross Limited. Prior to founding Mammoth, Paul was the Chief Operating Officer of ShopFast (sold to Coles in 2003). Paul has worked in the retail industry for 26 years with roles including General Manager of Caltex/Boral JV, Vitalgas. He is Chairman of Risk Committee.
    Mr Darren Stewart Executive Director May 2018
    Mr Stewart is a registered podiatrist and in 2004 co-founded the My FootDr Business with Greg Dower. In 2015, Darren and Greg saw the opportunity to grow their network of clinics through the acquisition of podiatry clinics. Before merging with Balance Podiatry Group in December 2016. Darren provides strategic leadership and direction to the Feet & Ankles business division.
    Mr Colin Jonathan Kangisser Non-Executive Director Nov 2020
    Mr Kangisser is a registered optometrist with over 30 years optical experience. He founded, grew and exited multiple retail chains including Optic Express and Kays Optical prior to holding executive leadership positions with the OPSM Group and founding TOC in 2005.
    Mrs Lisa Michelle Roach Executive Director Apr 2022
    Mrs Roach was a founding partner in several of the Allsports Clinics and has over 29 years of experience in the allied health industry; she was also a qualified and practicing physiotherapist for 10 years. Mrs Roach has held an Executive role and been heavily involved and influential within Healthia since IPO. Her current role is Chief Operations and People Officer for Healthia's Bodies & Minds, Feet & Ankles divisions. Mrs Roach has held board positions on Healthia's subsidiary entities since IPO.
    Ms Julia Murfitt General CounselCompany Secretary Feb 2022
    -
    Julia Murfitt General CounselCompany Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Citicorp Nominees Pty Limited 20,948,911 14.94%
    Hsbc Custody Nominees (Australia) Limited 18,024,648 12.86%
    J P Morgan Nominees Australia Pty Limited 11,317,234 8.07%
    Belaroo Pty Ltd 6,963,607 4.97%
    Bridell Pty Limited 5,134,628 3.66%
    Maximum (Nq) Pty Ltd 4,923,299 3.51%
    Bnp Paribas Noms Pty Ltd 3,812,058 2.72%
    Dlh Trading Pty Ltd 3,495,465 2.49%
    Ubs Nominees Pty Ltd 3,420,296 2.44%
    Jabez Fund Pty Ltd 3,069,444 2.19%
    Rom Group Pty Ltd 2,373,267 1.69%
    Maximum (Nq) Pty Ltd (ii) 1,815,670 1.30%
    Mr Milton Zevi Levine 1,625,025 1.16%
    Willeese Pty Limited 1,547,383 1.10%
    HSBC Custody Nominees (Australia) Limited A/C 2 1,409,627 1.01%
    Pacific Custodians Pty Limited 1,316,823 0.94%
    Gf & Lh Richards Super Pty Ltd 1,177,808 0.84%
    National Nominees Limited 1,078,424 0.77%
    Hgt Investments Pty Ltd 982,800 0.70%
    Dpc Investments Pty Ltd 967,317 0.69%

    Profile

    since

    Note